Sex differences in drug-induced changes in ventricular repolarization

Journal of Electrocardiology
Jose VicenteDavid G Strauss

Abstract

Heart rate corrected QT (QTc) interval prolongation is a predictor of drug-induced torsade de pointes, a potentially fatal ventricular arrhythmia that disproportionately affects women. This study assesses whether there are sex differences in the ECG changes induced by four different hERG potassium channel blocking drugs. Twenty-two healthy subjects (11 women) received a single oral dose of dofetilide, quinidine, ranolazine, verapamil and placebo in a double-blind 5-period crossover study. ECGs and plasma drug concentrations were obtained at pre-dose and at 15 time-points post-dose. Dofetilide, quinidine and ranolazine prolonged QTc. There were no sex differences in QTc prolongation for any drug, after accounting for differences in exposure. Sex differences in any ECG biomarker were observed only with dofetilide, which caused greater J-Tpeakc prolongation (p=0.045) but lesser Tpeak-Tend prolongation (p=0.006) and lesser decrease of T wave amplitude (p=0.003) in women compared to men. There were no sex differences in QTc prolongation for any of the studied drugs. Moreover, no systematic sex differences in other drug-induced ECG biomarker changes were observed in this study. This study suggests that the higher torsade risk in wome...Continue Reading

References

Feb 1, 1966·American Heart Journal·R E Mason, I Likar
Dec 1, 1993·JAMA : the Journal of the American Medical Association·R R MakkarM H Lehmann
Mar 21, 2000·Medical & Biological Engineering & Computing·B AcarM Malik
May 9, 2000·Clinical Pharmacology and Therapeutics·R E BentonR L Woosley
Mar 20, 2001·JAMA : the Journal of the American Medical Association·I RodriguezR L Woosley
Jan 11, 2007·Journal of Cardiovascular Electrophysiology·Donglin GuoGan-Xin Yan
Aug 28, 2007·The American Journal of Cardiology·Henriette Sloth PedersenUNKNOWN DIAMOND Study Group
Jan 30, 2009·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Fabio BadiliniNenad Sarapa
Jan 1, 2014·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Borje DarpoNorman Stockbridge
Dec 3, 2014·American Heart Journal·Jose VicenteDavid G Strauss
Mar 23, 2015·Journal of Electrocardiology·Jose VicenteDavid G Strauss
Apr 15, 2015·Journal of the American Heart Association·Jose VicenteDavid G Strauss
Jun 13, 2015·Circulation. Arrhythmia and Electrophysiology·JoEllyn M AbrahamBruce L Wilkoff

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.